CRDN Related Analyst Ratings
-
Wells Fargo Can't Rule Out Competing Bids for Ceradyne (CRDN)
-
ThinkEquity Upgrades Ceradyne (CRDN) to Buy
-
ThinkEquity Downgrades Ceradyne (CRDN) to Hold
-
Needham & Company Downgrades Ceradyne (CRDN) to Hold; Chopping Estimates
-
Needham & Company Maintains a 'Buy' on Ceradyne (CRDN); Cutting Estimates on Weakness in Solar
-
Needham & Company Reaffirms a 'Buy' on Ceradyne (CRDN); Mixed Results & Guidance; Higher Tax Rate Will Be Earnings Drag In 2012
-
Ceradyne (CRDN) Shares Nosedive Following DA Davidson Downgrade
-
Needham & Company Maintains a 'Buy' on Ceradyne (CRDN); Stock Rallies On Stronger Than Expected Q3; Mgmt Reaffirms Full-Year Outlook
-
Benchmark Cuts Price Target on Ceradyne (CRDN) Ahead of Earnings, But Sees Slight Upside for Q3
-
Needham & Company Maintains a 'Buy' on Ceradyne (CRDN); End Of 2011 Guidance Looks More Challenging, But Priced Into Stock
-
Benchmark Comments on Ceradyne (CRDN), Anticipates a Q2 Upside
-
Wedbush Downgrades Ceradyne (CRDN) to Neutral; Lofty Street Expectations & No Material Near-term Catalysts
-
DA Davidson Raises Price Target on Ceradyne (CRDN), New Contracts Increase Expectations
-
Needham & Company Reiterates a 'Buy' on Ceradyne (CRDN); Stronger Gross Margins Drive Q4 Upside EPS
-
Wedbush Upgrades Ceradyne (CRDN) to Outperform
-
ThinkEquity Upgrades Ceradyne (CRDN) to Buy
-
DA Davidson Upgrades Ceradyne (CRDN) to Buy, Raises Price Target to $37
-
Needham & Company Reiterates a 'Buy' on Ceradyne (CRDN); DoD Awards CRDN $56M ESAPI Plate Contract For Q4-Q1 Deliveries
-
Needham & Company Reiterates a 'Buy' on Ceradyne (CRDN); Q3 Results Miss Street Expectations, Bookings, Backlog Solid
-
Needham & Company Reaffirms a 'Buy' on Ceradyne (CRDN); Q3 Estimate As Confidence Grows In Solar
-
Needham & Company Reiterates a 'Buy' on Ceradyne (CRDN); Mgmt Reaffirms Full-Year Guidance At Investor Conference
-
Benchmark Upgrades Ceradyne (CRDN) to Buy; Expect Upcoming Body Armor Awards to Support Strong FY10-11
-
Needham & Company Upgrades Ceradyne (CRDN) to Buy; Growth Outlook For Non-Defense Business Brightens
-
Benchmark Initiates Coverage on Ceradyne (CRDN) with a Hold; Growing Solar Unlikely to Offset Deceleration in Body Armor
-
Jesup & Lamont Upgrades Harris Stratex Networks (HSTX) to Buy
-
Morgan Joseph Maintains a 'Hold' on Ceradyne (CRDN), Suspends Estimates
-
Wells Fargo Upgrades Ceradyne (CRDN) to Market Perform; XSAPI Thesis Confirmed
-
Needham & Co Resumes Coverage on Ceradyne (CRDN) with a Hold
-
DA Davidson Upgrades Ceradyne (CRDN) to Buy
-
ThinkEquity Downgrades Ceradyne (CRDN) to Accumulate
-
Wachovia Downgrades Ceradyne (CRDN) to Underperform; Reduces Estimates
-
DA Davidson Starts Ceradyne (CRDN) at Neutral
-
Matrix Lighthouse Rating Changes 2/27
-
Stanford Downgrades Ceradyne (CRDN) to Sell
-
Morgan Joseph Downgrades Ceradyne (CRDN) to Hold on Re-Bid of SAPI Program
-
Ceradyne (CRDN): Downgraded after a stealthy warning
-
Wachovia Upgrades Ceradyne, Inc. (CRDN) to Market Perform
-
Stanford Upgrades Ceradyne (CRDN) to Buy
-
Stanford Downgrades Ceradyne (CRDN) to Hold
-
Wachovia Securities Downgrades Ceradyne (CRDN) to Underperform
-
Mogan Joseph Upgrades Ceradyne (CRDN) to Buy
-
FBR Downgrades Ceradyne (CRDN) to Market Perform
-
Friedman Billings Upgrades Ceradyne (CRDN) to Outperform
-
Utendahl Upgrades Ceradyne (CRDN) to Overweight
-
Morgan Joseph Downgrades Ceradyne (CRDN) to Hold
-
Morgan Joseph Upgrades Ceradyne (CRDN) to Buy
-
Ceradyne (CRDN): Expect Tomorrow's Scheduled Business Update to be Positive - Broadpoint
-
Morgan Joseph Initiates Coverage on Ceradyne Inc. (CRDN) with a Hold
-
Wedbush Morgan downgrades Ceradyne (CRDN) to Hold
-
First Albany Starts Ceradyne (CRDN) at Neutral
Back to CRDN Stock Lookup
